Macular Degeneration Awareness Program Series: Vision Matters!
The Macular Degeneration Association will be hosting a series of awareness programs titled Vision Matters! throughout the United States to share information and provide age-related macular degeneration, diabetic retinopathy and glaucoma patients an opportunity to learn about the latest information surrounding treatments, clinical trials and  new drugs. There will also be a forum where patients and caregivers can exchange their questions and concerns with experts in the field of these eye diseases, as well as other patients.
Programs are currently scheduled for the following cities; San Jose, CA –May 9th, Phoenix, AZ- June 13thHauppauge, NY- June 27th, Chesterfield, MO- July 11th, Columbus, OH – August 1st,Elk Grove, IL-September 12th, Port Charlotte, FL- September 26th,Philadelphia, PA –October 10th, Baltimore, MD – October 17th, Nashville, TN-November 7th, The Villages, FL- November 14th.
These programs will feature general session presentations by world renowned retina specialists, and a question and answer session will then follow at the end of the talks for full interaction between the speakers and participants.
 Topics to be discussed at the seminar include:

 Space is limited, please call and reserve your place today. For more information please contact Donna Auger at donna@macularhope.org or by phone at 1-941-893-4387
About the Macular Degeneration Association:
The Macular Degeneration Association (MDA) is a national nonprofit health organization.
The mission of the organization is to find a cure for age-related macular degeneration, diabetic retinopathy and glaucoma and to improve the lives of those affected by these diseases through hope, education, support and empowerment all across the world.
To fulfill this mission, MDA funds research, publishes scientific findings and provides funding for national educational programs for patients with these diseases, their families, caregivers and healthcare providers.
Age-related macular degeneration, diabetic retinopathy and glaucoma are increasingly prevalent degenerative eye diseases affecting millions of aging seniors and adults. Our goal is to provide information about risk factors, genetic predisposition and proper diagnosis, as well as preventive efforts and treatment options that will likely reduce the most adverse effect, blindness.  
MDA is an IRS recognized 501 (c) (3) organization and contributions are tax-deductible to the extent permitted by law.
 

On